NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

VE6142021000088SUndetermined Publication Date: 2022-02-17BAYER PHARMA AG
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
BAYER PHARMA AG
Filing Date
2021-04-30
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

The present invention relates to a new class of high-relaxivity extracellular gadolinium chelate complexes, to methods of preparing said compounds, and to the use of said compounds as MRI contrast agents.